| Quest – Discovery Stage Research Projects | Neurona Therapeutics | Development of a Cellular Therapeutic for Treatment of Epilepsy |
$1,616,536 |
| Therapeutic Translational Research Projects | Neurona Therapeutics | Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. |
$3,828,714 |
| Therapeutic Translational Research Projects | Neurona Therapeutics | Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy |
$4,848,505 |
| Clinical Trial Stage Projects | Neurona Therapeutics | Inhibitory Interneuron Cell Therapy (NRTX-1001) for the Treatment of Drug-resistant Bilateral Temporal Lobe Epilepsy |
$13,999,983 |
| Clinical Trial Stage Projects | Neurona Therapeutics | Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy |
$7,999,999 |
| Progression Award – Discovery Stage Research Projects | Neurona Therapeutics | Global gene expression profiling of single inhibitory neurons derived from human stem cells |
$202,500 |
